SOPHiA GENETICS (SOPH)

• Market cap: $219M
• 1 day: 1.23%
• 5 days: -1.20%
• 1 month: 4.76%
• 3 months: -13.84%
• 6 months: -28.42%
• Year to date: -31.68%
• 1 year: -30.67%
• 5 years: -80.31%
• 10 years: -80.31%

About: Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Employees: 449

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

2,000% more call options, than puts

Call options by funds: $21K | Put options by funds: $1K

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

0.16% less ownership

Funds ownership: 27.5% [Q2] → 27.34% (-0.16%) [Q3]

3% less funds holding

Funds holding: 31 [Q2] → 30 (-1) [Q3]

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

21% less capital invested

Capital invested by funds: $82.3M [Q2] → $65.2M (-$17.2M) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $11 233% upside
• Avg. target: $11 233% upside
• High target: $11 233% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Craig-Hallum

233% upside $11

Buy Initiated

18 Dec 2024